What is the current stock price of Franklin Covey Co. (FC)?

As of the latest market data, Franklin Covey Co. (FC) is trading at $23.93. The stock has seen a gain of 1.83% today.

Does Franklin Covey Co. (FC) pay a dividend?

Based on current data, Franklin Covey Co. does not have a confirmed active dividend policy.

What is the market cap of Franklin Covey Co.?

The current market capitalization of Franklin Covey Co. (FC) is approximately unavailable.

FC

Franklin Covey Co.·Industrials

23.93

1.830%(+0.43)

Close Price

27.50

14.919%(+3.57)

After Hours

Last Updated: — ET

52W L: $11.1652W H: $24.70

FC NEWS

gurufocus.com

15h ago

FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)

[url="]Ironwood Pharmaceuticals, Inc.[/url] (Nasdaq: IRWD), a biotechnology company developing and commercializing life changing therapies for people living wi

businesswire.com

15h ago

FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life changing therapies for people living with gastrointestinal (GI) and rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the use of LINZESS® (linaclotide) in pediatric patients 2 years of age and older with functional constipation (FC). LINZESS was previously approved for pediatric patients 6 years and older with FC. With thi.

gurufocus.com

6d ago

80% of Individual Contributors Say Their Manager's Approach to AI is Hands-Off, FranklinCovey Research Finds

As organizations race to capture the benefits of artificial intelligence, research from [url="]FranklinCovey[/url] Institute reveals a critical obstacle: most

businesswire.com

6d ago

80% of Individual Contributors Say Their Manager's Approach to AI is Hands-Off, FranklinCovey Research Finds

SALT LAKE CITY--(BUSINESS WIRE)-- #AI--As organizations race to capture the benefits of artificial intelligence, research from FranklinCovey Institute reveals a critical obstacle: most employees feel they are navigating AI alone, without meaningful support or guidance. Eighty percent of individual contributors describe their manager's approach to AI as “hands-off,” which underscores a widening gap between AI's potential and how it's actually used at work. FranklinCovey's 2025 AI General Attitudes Sur.

marketbeat.com

May 19

Diploma H1 Earnings Call Highlights

Diploma LON: DPLM reported what management described as a “very strong” first half for the six months ended March 31, 2026, with double-digit organic growth, higher margins and upgraded full-year expectations.

gurufocus.com

May 17

United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that full results of its ADVANCE OUTCOMES study are being present

Company Profile

Franklin Covey Co. provides training and consulting services in the areas of execution, sales performance, productivity, customer loyalty, and educational improvement for organizations and individuals worldwide. The company operates through three segments: Direct Offices, International Licensees, and Education Practice. It also provides a suite of individual-effectiveness and leadership-development training and products. The company was incorporated in 1983 and is headquartered in Salt Lake City, Utah.

Sector

Industrials

Industry

Consulting Services

Employees

1,084

IPO Date

1992-06-03

Beta

0.78

Websitewww.franklincovey.com↗